Skip to content

A Clinical Trial to study the Effect of Unani formulation in Chronic Rhinosinusitis

The Efficacy of Unani formulation in Waram tajaweef anaf muzmin (Chronic Rhinosinusitis)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/012244
Enrollment
30
Registered
2018-02-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic Rhinosinusitis

Interventions

Intervention1: Unani formulation: Ingredients: 1. Gule banafsha (Viola odorata) 7g 2. Ustukhuddoos (Lavandula stoechas)

Sponsors

National Institute of Unani Medicine NIUM Bengaluru
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Both gender •>=8 weeks of persistent symptoms •Meet >=2 of 5 major symptoms criteria: ï?? Facial pain and pressure ï?? Facial Congestion ï?? Nasal obstruction ï?? Nasal discharge ï?? Olfactory disturbance (Smell) •X-ray of PNS (Waterâ??s view) shows haziness/ opacity and may show free fluid level.

Exclusion criteria

Exclusion criteria: • Pregnancy and Lactation. • Patients with known systemic and metabolic diseases. • Patients with the history of trauma and accidents. • Diagnosed cases of external injuries, nasal polyp, nasal growth and adenoids

Design outcomes

Primary

MeasureTime frame
Primary outcome: Relief of Major SymptomsTimepoint: Primary outcome: This was assessed by using VAS and SNOT-22 scores.

Secondary

MeasureTime frame
Secondary outcome: changes in X-ray findings.Timepoint: Secondary outcome: Assessed by X-ray findings.

Countries

India

Contacts

Public ContactMohammad Irfan Ansari

National Institute of Unani Medicine

drmuzaffar79@gmail.com9590366192

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026